Study guide

17.1 Surgical Wounds, Surgical Site Infection & Dehiscence

Certified Wound Specialist Physician CWSP

Track your progress as you read

Finished sections get a check mark.

1 Introduction

About the CWSP Exam

2 Chapter 1: Integumentary Anatomy & Wound Healing Biology

1.1 Skin Anatomy, Microstructure & Epidermal-Dermal Barrier Function 1.2 Acute vs Chronic Wound Healing Phases & Cellular Kinetics 1.3 Extracellular Matrix Composition, Collagen Architecture & MMP Regulation

3 Chapter 2: Musculoskeletal & Neurologic Anatomy

2.1 Musculoskeletal Anatomy of the Leg & Foot 2.2 Neuroanatomy & Nerve Physiology for Wound Care

4 Chapter 3: Cell Signaling, Biofilm & Barriers to Healing

3.1 Growth Factors, Cytokines & Angiogenic Pathways 3.2 Biofilm Microbiology, Quorum Sensing & Phenotypic Resistance 3.3 Cellular Senescence, Hypoxia & Inflammatory Arrest 3.4 Metabolic, Steroid & Nutritional Impairments in Wound Healing

5 Chapter 4: Patient Evaluation & Vascular Diagnostics

4.1 Comprehensive Patient & Periwound Physical Examination 4.2 Noninvasive Macrovascular Hemodynamics: ABI, TBI & Segmental Pressures 4.3 Microvascular Perfusion Diagnostics: TcPO2, SPP & Near-Infrared Spectroscopy 4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts

6 Chapter 5: Pain, Risk, Functional & Nutrition Assessment

5.1 Wound Pain Assessment 5.2 Risk Assessment Tools & Risk Stratification 5.3 Functional & Cognitive Assessment 5.4 Nutrition Screening & Assessment

7 Chapter 6: Imaging, Biopsy, Atypical Wounds & Neuropathy

6.1 Musculoskeletal Imaging for Osteomyelitis & Deep Space Infections 6.2 Diagnostic Tissue Biopsy, Culture Techniques & Quantitative Microbiology 6.3 Diagnostic Differential of Atypical & Malignant Ulcerations 6.4 Comprehensive Diabetic Peripheral Neuropathy & Biomechanical Assessment

8 Chapter 7: Wound Bed Preparation, Debridement, Dressings & Topical Agents

7.1 TIME Principle & Wound Bed Preparation Framework 7.2 Surgical, Sharp, Enzymatic, Autolytic & Biosurgical Debridement Modalities 7.3 Advanced Wound Dressings, Exudate Control & Moisture Balance 7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals

9 Chapter 8: Cellular & Tissue-Based Products, NPWT & Hyperbaric Oxygen

8.1 Cellular, Acellular & Matrix-Like Advanced Biologics (CTPs) 8.2 Negative Pressure Wound Therapy (NPWT) & Instillation Protocols 8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety

10 Chapter 9: Biophysical Technologies: Electrical Stimulation & Ultrasound

9.1 Electrical Stimulation for Wound Healing 9.2 Therapeutic Ultrasound in Wound Care

11 Chapter 10: Revascularization, Antimicrobial Stewardship & Offloading

10.1 Revascularization for Limb Salvage 10.2 Systemic Antimicrobial Stewardship & Deep Infection Management 10.3 Mechanical Offloading, Pressure Redistribution & Total Contact Casting

12 Chapter 11: Surgical Closure & Healing Complications

11.1 Surgical Closure, Skin Grafts, Flaps & Amputation Levels 11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring

13 Chapter 12: Nutrition Therapy & Case Review

12.1 Nutrition Therapy for Wound Healing 12.2 Case Review: Synthesizing Data, Outliers & Prognosis

14 Chapter 13: Diabetic & Ischemic Lower-Extremity Wounds

13.1 Diabetic Foot Ulcers: Pathophysiology, Staging & Limb Salvage 13.2 Peripheral Arterial Disease & Ischemic Extremity Ulcerations 13.3 Mixed Arterial-Venous Disease & Complex Diagnostic Dilemmas

15 Chapter 14: Venous Disease, Pressure Injuries, Lymphedema & Edema

14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression 14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention 14.3 Lymphedema, Phlebolymphedema & Complete Decongestive Therapy 14.4 Edema: Systemic vs. Local Causes

16 Chapter 15: Inflammatory, Calcific, Medication-Induced & Dermatologic Wounds

15.1 Autoimmune & Inflammatory Ulcerations: Pyoderma Gangrenosum & Vasculitis 15.2 Calciphylaxis & Radiation Tissue Injury 15.3 Medication-Induced & Hematologic Atypical Wounds 15.4 Dermatologic Conditions That Cause or Complicate Wounds

17 Chapter 16: Traumatic Wounds, Burns & Frostbite

16.1 Traumatic Wounds: Lacerations, Bites, Degloving & Open Fractures 16.2 Thermal Burns & Frostbite

18 Chapter 17: Surgical, Infectious & Pediatric Wounds

17.1 Surgical Wounds, Surgical Site Infection & Dehiscence 17.2 Infectious Causes of Wounds: Necrotizing, Mycobacterial, Fungal & Other Infections 17.3 Pediatric Wound Care

19 Chapter 18: Reimbursement, Regulation & Documentation

18.1 CPT Coding, Modifiers & Documentation for Debridement and Biologics 18.2 Regulatory Compliance, CMS Quality Programs & Hospital-Acquired Conditions 18.3 Documentation, Legal Concepts & Confidentiality

20 Chapter 19: Ethics, Adherence, Epidemiology & Evidence-Based Practice

19.1 Clinical Ethics, Informed Consent & Palliative Wound Management 19.2 Patient Adherence & Psychosocial Care 19.3 Epidemiology of Chronic Wounds 19.4 Research Literacy, Evidence-Based Medicine & Quality Improvement

17.1 Surgical Wounds, Surgical Site Infection & Dehiscence

Key Takeaways Explain This Topic AI

The CDC classifies surgical wounds as class I clean, class II clean-contaminated, class III contaminated, and class IV dirty-infected, and NHSN defines surgical site infection as superficial incisional, deep incisional, or organ/space infection within 30 or 90 days depending on the procedure.

Evidence-based SSI prevention includes treating remote infections, clipping rather than shaving hair, alcohol-based skin antisepsis (chlorhexidine-alcohol reduced SSI compared with povidone-iodine in a 2010 trial), prophylactic antibiotics timed before incision and not continued after closure in clean and clean-contaminated cases, glucose below 200 mg/dL, and normothermia.

Fascial dehiscence usually occurs around postoperative days 5 to 8 and is often heralded by a sudden gush of serosanguineous ("salmon-colored") fluid; evisceration is a surgical emergency managed with a sterile saline-moistened dressing and return to the operating room.

Enterocutaneous fistula output is low under 200 mL/day, moderate 200 to 500 mL/day, and high over 500 mL/day; management follows sepsis control, nutrition, defining the anatomy, and planned procedure, and the FRIENDS factors predict failure of spontaneous closure.

Closed-incision NPWT is suggested by the World Health Organization for high-risk primarily closed surgical incisions, and surgical wounds that must heal by secondary intention need the same wound bed preparation principles as chronic wounds.

Last updated: September 2026

17.1 Surgical Wounds, Surgical Site Infection & Dehiscence

Core Clinical Principle: Most surgical wounds heal quickly, but those that become infected, separate, or form fistulas turn into complex wounds that cost patients months. Wound specialists should know how surgical site infections are defined and prevented, how to recognize dehiscence early, and how to manage open surgical wounds and fistulas.

The CWSP outline lists surgical and surgical procedure wounds under Etiological Considerations. Closure techniques, grafts, and flaps are covered with surgical closure.

Surgical Wound Classification (CDC)

Class Definition Examples

I – Clean Uninfected, no inflammation; respiratory, alimentary, genital, and urinary tracts not entered Hernia repair, thyroidectomy

II – Clean-contaminated Controlled entry into those tracts without unusual contamination Elective cholecystectomy, colectomy with bowel preparation

III – Contaminated Open fresh accidental wounds, major breaks in sterile technique, gross spillage from the gastrointestinal tract Penetrating trauma under 4 hours, bowel spillage

IV – Dirty-infected Old traumatic wounds with devitalized tissue, existing infection, or perforated viscera Perforated diverticulitis with abscess

Surgical Site Infection Definitions (CDC NHSN)

  • Type Tissue Involved Time Window
  • Superficial incisional Skin and subcutaneous tissue of the incision Within 30 days
  • Deep incisional Fascia and muscle Within 30 or 90 days, depending on the procedure category

Organ/space Any part of the body deeper than the fascia opened or manipulated during surgery (for example, intra-abdominal abscess) Within 30 or 90 days, depending on the procedure category

Signs include pain, tenderness, localized swelling, erythema, warmth, purulent drainage, and deliberate opening of the incision by the surgeon with a positive culture or clinical diagnosis. Stitch abscesses alone do not count as SSI.

Risk Factors and Prevention

Patient Factors Procedure Factors

Diabetes and perioperative hyperglycemia, obesity, smoking, malnutrition, immunosuppression, Staphylococcus aureus colonization, remote infection, advanced age, radiation Long operations, contamination class, hypothermia, blood transfusion, poor hemostasis, dead space, excessive tissue trauma, emergency surgery

Evidence-based prevention measures (drawn from CDC 2017 and WHO guidelines):

Treat remote infections before elective surgery and encourage smoking cessation.

Remove hair only when needed, with clippers , not razors.

Alcohol-based skin antisepsis ; in a 2010 randomized trial (Darouiche and colleagues), chlorhexidine-alcohol lowered SSI after clean-contaminated surgery to 9.5% compared with 16.1% with povidone-iodine.

Prophylactic antibiotics given within 60 minutes before incision (120 minutes for vancomycin and fluoroquinolones), redosed for long procedures, and not continued after closure for clean and clean-contaminated operations.

Perioperative glucose below 200 mg/dL in all patients, with or without diabetes.

Normothermia and adequate oxygenation.

S. aureus decolonization (such as nasal mupirocin with chlorhexidine bathing) for carriers undergoing cardiac and orthopedic surgery.

Closed-incision NPWT: WHO guidelines suggest prophylactic NPWT on primarily closed incisions in high-risk procedures, considering resources.

Managing SSI and Other Early Complications

Superficial SSI: Open the incision, drain, cleanse, and pack or dress; antibiotics are added for cellulitis or systemic signs.

Deep and organ/space SSI: Imaging, drainage (often percutaneous or operative), and targeted antibiotics.

Seroma: Serous fluid collection; small collections resolve, larger ones need aspiration or drains.

Hematoma: Raises infection and flap loss risk; evacuate expanding or large collections and review anticoagulation.

Necrotizing infection: Pain out of proportion, rapidly spreading erythema, or crepitus near an incision needs emergency surgical exploration.

Dehiscence and Evisceration

Superficial dehiscence separates skin and subcutaneous tissue and is managed as an open wound, often with moist dressings or NPWT.

Fascial dehiscence most often occurs around postoperative days 5 to 8 . A sudden gush of serosanguineous ("salmon-colored") fluid from an abdominal incision is a warning sign.

Evisceration (bowel protruding through the wound) is a surgical emergency : keep the patient supine with knees flexed, cover the viscera with sterile saline-moistened dressings , keep NPO, and return to the operating room.

Risk factors: Infection, obesity, malnutrition, corticosteroids, chronic cough, ascites, emergency surgery, and poor closure technique.

Special Surgical Wounds

Sternal wounds: Deep sternal wound infection and mediastinitis are serious; bilateral internal mammary artery harvest in patients with diabetes and obesity increases risk. Treatment combines debridement, NPWT as a bridge, antibiotics, and muscle flap closure.

Open abdomen: Temporary abdominal closure with NPWT systems protects viscera while swelling resolves.

Pilonidal and perineal wounds: Heal slowly by secondary intention; off-midline closure techniques and NPWT may help.

Surgical wounds healing by secondary intention: Apply the same principles as chronic wounds (debridement, moisture balance, infection control, nutrition).

Enterocutaneous Fistulas

  • Output Classification
  • Under 200 mL/day Low output
  • 200 to 500 mL/day Moderate output
  • Over 500 mL/day High output

Management (SNAP): S epsis control and skin protection, N utrition (often parenteral for high output) and fluid and electrolyte replacement, A natomy defined with imaging, and P lanned procedure, usually delayed several months if the fistula does not close. Protect skin with pouching systems, wound managers, and barrier products; NPWT can be used with fistula isolation devices in selected wounds.

FRIENDS factors that prevent spontaneous closure: F oreign body, R adiation, I nflammatory bowel disease or infection, E pithelialization of the tract, N eoplasm, D istal obstruction, and S teroids (some versions use short tract length instead).

  • Clinical Traps
  • Trap 1: Treating a Salmon-Colored Gush With a Dressing Change

Serosanguineous drainage from an abdominal incision around day 5 to 8 is fascial dehiscence until proven otherwise. Examine the fascia and involve the surgeon immediately.

Trap 2: Continuing Prophylactic Antibiotics for Days

Extending prophylaxis after closure of a clean or clean-contaminated operation does not lower SSI and promotes resistance and C. difficile infection.